The technology of tomorrow …

The fastest gateway to a successful launch is by choosing the right lead compound early. N2MO’s ex vivo models can provide guidance to you in your early drug discovery choices!

Contact us

N2MO A/S
Islandsbrygge 79C, 8502
DK-2300 København S
Denmark

Phone: +45 3134 4896

admin

About N2MO

This author has not yet filled in any details.
So far N2MO has created 4 blog entries.

Data presented by Lundbeck in Berlin

Lundbeck presented data at the 4th International Conference Clinically Relevant Drug Transporters, 22 – 23 2013 in Berlin

Recent data obtained by using our optimized model was presented by Lundbeck in Berlin at the 4th International Conference Clinically Relevant Drug Transporters – 22 – 23 April, 2013.

In summary the data shows:

that our ex vivo grasshopper model […]

By |April 10th, 2013|Conferences|

Review: Novel Models for Assessing Blood-Brain Barrier Drug Permeation

Have you read the most recent review “Novel Models for Assessing Blood-Brain Barrier Drug Permeation”?
Please find link to the review ‘Novel models for assessing blood–brain barrier drug permeation’ by Geldenhuys et al. (Posted online on April 3 2012, in Expert Opinion on Drug Metabolism & Toxicology

By |May 1st, 2012|Research|

Funding for The Project “Insect Models for Drug Discovery”

The Project “Insect Models for Drug Discovery” has received funding from the Danish National Advanced Technology Foundation.
The vision of the project is to establish insects, as a novel model organism in preclinical research.

EntomoPharm has previously developed two models for ADME drug screening in locusts. From this work and from preliminary insect studies it is evident […]

By |January 2nd, 2012|Funding|

N2MO has been granted European (EPO) Patent

N2MO has been granted European (EPO) Patent for Screening Methods employing insects with Blood Brain Barrier
The patent covers insect models that are aimed to reflect vertebrate blood-brain barrier (BBB) penetration.

The value of the insect BBB model is that it can be just as predictive as expensive and time consuming animal models, and by using the […]

By |May 28th, 2009|About N2MO, Patents|